To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

COVID-19 forces Lithuania to revisit Boxer/Vilkas

16th March 2021 - 16:45 GMT | by Flavia Camargos Pereira in London

RSS
The Lithuanian MND is seeking solutions in order to keep the Boxer/Vilkas programme on track. The Vice Minister of National Defence recently held a meeting with OCCAR, ARTEC and KMW to discuss potential solutions to overcome the economic effects of the global COVID-19 pandemic.

The economic impact of COVID-19 has forced the Lithuanian Ministry of National Defence (MND) to reassess the procurement of Boxer IFVs (designated Vilkas by the Lithuanian Army). The armed forces are seeking solutions in order to keep the acquisition schedule on track.

Vice Minister of National Defence, Vilius Semeška held a meeting on 5 March with representatives of the NATO procurement agency OCCAR, the German consortium ARTEC and manufacturer Krauss-Maffei Wegmann (KMW) to discuss progress on the programme, the delivery timeline, implementation difficulties and potential solutions.

Semeška claimed that, although the programme is a priority for the MND and a cornerstone of Lithuanian

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 2 free stories per week
  • Daily news round-up email service
  • Access to all Decisive Edge email newsletters
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
Start your free trial
Flavia Camargos Pereira

Author

Flavia Camargos Pereira


Flavia Camargos Pereira is a North America editor at Shephard Media. She joined the company …

Read full bio

Share to

Linkedin